European startups are leveraging AI to revolutionize healthcare by enhancing diagnostics and improving personalized care.In Q1 of 2025, European healthtech startups secured €12.79 billion in private funding, with AI-driven startups emerging as key players.Better Medicine, based in Estonia, uses AI to improve the early detection of kidney tumors through accurate CT scan analysis.Biolevate, headquartered in Paris, streamlines knowledge management in healthcare to fuel scientific innovation.Bioptimus, a Paris-based startup, focuses on building a universal AI foundation model for biology to accelerate scientific discovery.Elea, a German startup, enhances pathology in clinical diagnostics with AI, improving turnaround times and accuracy.Graph Therapeutics in Vienna is revolutionizing inflammation and immunology drug discovery by applying AI to identify drug candidates.Kardi Ai from the Czech Republic offers at-home cardiac monitoring through AI-powered wearable tech, reducing hospital visits.Okeiro in Paris provides an AI platform for chronic disease and transplant care, enabling early detection and personalised treatment pathways.Orakl Oncology in Villejuif combines biology and AI for oncology drug development, utilizing tumour avatars to simulate drug responses.